Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Docosahexaenoic Acid Augmentation of Cortical Attention Networks in ADHD

NCT01883817 is registered in ClinicalTrials.gov with University of Cincinnati as lead sponsor.

NCT NCT01883817
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01883817 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Docosahexaenoic Acid Augmentation of Cortical Attention Networks in ADHD
Lead sponsor
University of Cincinnati
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2013
Completion date
March 3, 2017
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

attention deficit disorder